These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 26494481)
41. [Vision disorders in inflammatory-rheumatic diseases]. Bernauer W Ther Umsch; 1996 Jan; 53(1):58-67. PubMed ID: 8650624 [TBL] [Abstract][Full Text] [Related]
42. Rheumatoid arthritis and ocular involvement. Shaw C; Banik S; Islam MN; Biswas MC; Biswas G; Biswas S J Indian Med Assoc; 2003 Sep; 101(9):537-8. PubMed ID: 15168989 [TBL] [Abstract][Full Text] [Related]
43. The eye: A window to the soul of the immune system. Perez VL; Saeed AM; Tan Y; Urbieta M; Cruz-Guilloty F J Autoimmun; 2013 Sep; 45():7-14. PubMed ID: 23871641 [TBL] [Abstract][Full Text] [Related]
44. Spectrum Of Ocular Manifestations Of Rheumatic Autoimmune Diseases: A Tertiary Care Experience In Pakistan. Uddin Z; Khan A; Haroon M; Faiq M; Rabbani S; Lashari NA J Ayub Med Coll Abbottabad; 2021; 33(4):612-616. PubMed ID: 35124918 [TBL] [Abstract][Full Text] [Related]
45. [The ocular manifestations in rheumatoid polyarthritis]. Koos MJ; Suşan L; Muntean A; Lehaci C Oftalmologia; 1999; 46(1):15-20. PubMed ID: 10641082 [TBL] [Abstract][Full Text] [Related]
46. [Diseases of the outer eye in rheumatoid arthritis]. Feist E; Pleyer U Z Rheumatol; 2010 Jul; 69(5):403-10. PubMed ID: 20559644 [TBL] [Abstract][Full Text] [Related]
49. Ocular vasculitis: a multidisciplinary approach. Herbort CP; Cimino L; Abu El Asrar AM Curr Opin Rheumatol; 2005 Jan; 17(1):25-33. PubMed ID: 15604901 [TBL] [Abstract][Full Text] [Related]
50. The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases. Fabiani C; Sota J; Tosi GM; Franceschini R; Frediani B; Galeazzi M; Rigante D; Cantarini L Clin Rheumatol; 2017 Oct; 36(10):2307-2318. PubMed ID: 28032234 [TBL] [Abstract][Full Text] [Related]
54. [Indication and effect of immunosuppression in patients with scleritis]. Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507 [TBL] [Abstract][Full Text] [Related]
55. [Useful examinations and therapies in immunologic diseases]. Martenet AC Klin Monbl Augenheilkd; 1993 May; 202(5):474-8. PubMed ID: 8377420 [TBL] [Abstract][Full Text] [Related]
56. The eye in systemic vasculitis. Menezo V; Lightman S Clin Med (Lond); 2004; 4(3):250-4. PubMed ID: 15244360 [TBL] [Abstract][Full Text] [Related]
57. Immune tolerance and autoimmune uveoretinitis: the role of the ocular microenvironment. Takeuchi M Immunotherapy; 2011 Sep; 3(9):1103-11. PubMed ID: 21913832 [TBL] [Abstract][Full Text] [Related]
58. Ocular lesions of bovine malignant catarrhal fever. Whiteley HE; Young S; Liggitt HD; DeMartini JC Vet Pathol; 1985 May; 22(3):219-25. PubMed ID: 4002535 [TBL] [Abstract][Full Text] [Related]
59. [CLINICAL MANIFESTATIONS OF AUTOIMMUNE DISEASES]. Shyriaiev H; Sar S; Tomkins-Netzer O Harefuah; 2024 May; 163(5):305-309. PubMed ID: 38734944 [TBL] [Abstract][Full Text] [Related]